Chiesi has more than 75 years' experience in healthcare innovation, specialising in respiratory, cardiovascular, musculoskeletal and neonatal treatments. The pharmaceutical company is research-driven and invests around 15% of its turnover into research and development. It works closely with healthcare professionals (including the NHS) to develop treatments that meet patient needs. From its small, family origins in Italy, Chiesi now has a global presence, with research centres in Italy, France, the UK and the US. It employs more than 3,700 people and its medicines and technologies are available in more than 60 countries. In the UK, Chiesi has enjoyed double-digit growth for five continuous years and offers employees the chance to work in a dynamic, fast-paced environment.
